BMS-986416

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986416, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors [Phase 1]